Podcasts about Ravin

In today's story, a little boy runs out of many things and wonders if everything in the world runs out! So, is there something he finds that doesn't run out?Let's listen to the story and find out.Free activity sheet available at www.rituvaish.com/infinite-loveSend your artwork to rituvaish@gmail.com.TranscriptInfinite LoveChildren, we run out of many things during our day, but is there something you cannot run out of?Ravin, a happy five-year-old boy, lived with his parents, his grandmother, and his older sister. They always helped one another, and their home overflowed with love.Every night at bedtime, Grandma read Ravin a lovely storybook and reminded him, “Always keep loving everyone.”One night, Ravin asked thoughtfully, “You tell me to love everyone, Grandma. But if I keep giving love, won't my love finish one day?”Grandma smiled gently and said, “No, my dear. Love never finishes, no matter how much you give.”The next day was Sunday. Ravin went to the playground early in the morning and began playing a game of cricket with his friends. It was great fun, but the sun was shining brightly, and soon Ravin felt very thirsty. He gulped down all the water from his bottle. After some time, his throat felt dry again.He picked up his bottle and exclaimed, “Oh no! I've run out of water!”One of his friends heard him and quickly shared his own water. Ravin felt loved. He thanked his friend.Children, when do you feel loved?That's great.Now listen aheadWhen Ravin returned home, he had to work on a project due on Monday—Best Out of Waste. Before starting, he rushed to the bathroom for a refreshing shower. As he pressed the shower gel bottle, he cried out, “Oh no! The shower gel has finished!”“Mom! Dad!” he called.His father came and handed him a new bottle of shower gel. Ravin felt loved again—clean, fresh, and happy. He thanked his fatherSoon, he spread out paper rolls, soap boxes, bottle caps, and other waste materials to make a sculpture of the Himalayan ranges. But no matter how hard he tried, the mountains wouldn't stand. Ravin felt disappointed and was running out of ideas.Seeing his worried face, his mother said gently, “Why don't you support the mountains with something?”Ravin's eyes lit up. “Thanks for this great idea mom!”He ran to the garden, collected some wooden sticks, and soon his mountains stood tall. He planned to cover the mountains with brown paper and add tiny trees. Excited, as he squeezed the glue bottle, he exclaimed, “Oh no! I've run out of glue!”His older sister, who was working on her own assignment, rushed over and shared her glue with him. Once again, Ravin felt loved. He thanked his sister.The sculpture was finally ready, and Ravin was delighted.After Grandma finished reading the bedtime story, she asked, “How was your day, Ravin?”Ravin smiled and said, “Oh Grandma, I felt so loved today. I ran out of water, shower gel, ideas, and glue—but I never ran out of love.”Grandma hugged him, knowing her lesson had come true.       

Réécoutez FG mix invite le Buddha Bar Paris avec Ravin du mardi 23 décembre 2025

Réécoutez FG mix invite le Buddha Bar Paris avec Ravin du mardi 16 décembre 2025

Dr. Pedro Barata and Dr. Ravin Garg discuss strategies to increase trial representation, including leveraging trial navigators and prioritizing pragmatic trial models, as featured in the ASCO Educational Book article, "Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care." TRANSCRIPT Dr. Pedro Barata: Hello, and welcome to By the Book, a podcast from ASCO featuring compelling perspectives from authors and editors of the ASCO Educational Book. I'm Dr. Pedro Barata. I am a medical oncologist at University Hospital Seidman Cancer Center and an associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I am also the associate editor of the ASCO Educational Book. We know that in recent years, the oncology community has increasingly prioritized the need to modernize clinical trial eligibility, reduce patient burden, and enhance diversity in trial participation. On that note, today we will be speaking about ways to enhance access to clinical trials with Dr. Ravin Garg. He is a hematologist oncologist at Maryland Oncology Hematology and also an assistant professor of oncology at Johns Hopkins Hospital in Baltimore. Dr. Garg is also the co-author of a fantastic paper in the ASCO Educational Book titled, "Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care."  Dr. Garg, welcome. Thanks for being here, and congrats on your paper. Dr. Ravin Garg: Thank you for having me, Pedro. I am excited to be here. Dr. Pedro Barata: [KI1]  Your paper is a wonderful, multidisciplinary piece that actually features perspectives from the different stakeholders, right? The patient advocacy, industry, community practice, and academia about these challenges in making trials more available. This podcast is a wonderful platform. It reaches out to a lot of folks within our community. So, I will start by asking you the obvious. Why do you think it is a must read for our community, for our listeners? Dr. Ravin Garg: So Pedro, thanks again for inviting me. You do a great job with these podcasts.  So, I think first and foremost, oncologists right now are under a lot of stress, just in terms of clinical volume. There is concern for research money, and how we get the best care for our patients. So I think this article is very important because it helps bring together, as you had mentioned, the stakeholders throughout academic to community practice and everywhere in between, and try to find how, as a team with different oncologists who partake in different aspects of oncology, can come together to streamline the process to try to get our patients on trials, or certainly have them have availability of trials, just if they are interested in going on them. Being in practice, we have had several challenges that we can talk about throughout this podcast, but I think it is a very important paper because it recognizes that at the end of the day, it takes a team effort for all of us in academics, community, industry, and pharmaceuticals to really come together as a team to really help put forth the trials for our patients. Dr. Pedro Barata: So, from the perspective of a community oncologist, how do you put together, or maybe you can describe some of the challenges that you see to increase trial participation in the community? Dr. Ravin Garg: Yes, Pedro, that is a great question, and it is something that I keep on thinking about and trying to find ways to be better at it myself. But I will say some of the challenges as a community doctor that I have seen for myself and talking to other colleagues. Number one, I do think there is a lot of stress on doctors in the community in general, Pedro. Oftentimes we are tasked to see a wide smorgasbord of patients, so we may not have the luxury of being a specialist in any particular tumor subtype. Like oftentimes, we will have to see lung cancer, the next one will be breast cancer, the next one could be CML, the next one could be thrombocytopenia. And as you know better than I do, Pedro, the field in each one of these disciplines is changing so rapidly: molecular genomics, radioligand treatments, different imaging tests, MRD testing for some of our hematologic malignancies. And I think one challenge we have in community is just keeping up with the basics of Oncology 101. In the process of doing that, it can be very difficult to sometimes remember that we have very exciting trials available for our patients. So, I think a lot of it is the day in and day out of being an oncologist is so taxing at times that oftentimes a research trial is not the first thing in our head space when we see a patient. I think number two, Pedro, at least in the community, and perhaps this is with academics too, is that we are bombarded, I would say, by a lot of messaging these days. We have in-baskets to go through, labs to go through, things of that nature. And in the process of a patient visit, seeing them, doing an exam, taking a history, trying to go over the NCCN guidelines on best practice for how to manage their care, at least for me at times, it is very hard to remember, "Hey, there might be a great trial available, whether within our network or maybe partnering with an academic center." So getting through a day can be fraught with a lot of peril and just difficulties, I would say. And I would say number three, Pedro, at least as, you know, I am in a private practice where I do see a wide range of benign and malignant hematology and solid tumors, so I would not call myself a specialist. And I think the challenge with that, at least for trials, Pedro, is that when you are a specialist or perhaps you are focusing on a couple of disease subtypes, you become more of an authoritative voice in those types of tumors, and you might be more aware of the trials within your network or perhaps in proxy with an academic center that you can offer your patient. So I think when sometimes we spread ourselves too thin, it can be very hard to be a thought leader, if you will, in a particular subtype of a malignancy, let's say, and maybe not be aware of a trial that could be really well-suited for your patient. In terms of ideas that myself and colleagues have had in terms of helping mitigate against some of these, I would say, setbacks or issues in the practice for trial enrollment, some of the things we have talked about, Pedro, is, number one, is we do partner with academic centers. So we live here in Maryland. We have several really fantastic academic centers. So, you know, oftentimes, not just within our practice of Maryland Oncology Hematology, we have a lot of great trials available here too, for certain, but in addition to that, we will often times work with doctors at Georgetown, Johns Hopkins, and Maryland if they have a compelling trial that we do not have within our network. It is really of the patient's interest, Pedro, to reach out to them in a collaborative manner to see if they have a trial that might be really compelling for your patient. So I do find myself collaborating a lot with colleagues in, like talented like yourself in academics. You know, I think you do a lot of GU malignancies. So as an example, like partnering with colleagues who are GU experts and say, "Hey, we have a patient with stage IV renal cell. These are the standard options I know, but are there any trials that you might have available?" I think the other thing that has been very helpful for us is having navigators within research, Pedro. Like as an example, what has really helped the uptake of trial enrollment for our center in Annapolis is having a research navigator because often times what they can do is, a priori, Pedro, before you see the patient and you are kind of formulating a standard of care treatment plan perhaps, they might tug you on the shirt and say, "Hey, we have a great trial here through Sarah Cannon, or there might be something else out there." And being aware of that when you go into a patient's room really provides a nice arena, if you will, to go and say, "The standard of care is here, but hey, we have a trial option that might be well suited for you, maybe perhaps even better, that we can talk about, too." So having research support in the community is really a huge boon, I think, Pedro, for us to really increase our enrollment for patients onto trials. Dr. Pedro Barata: Yes, I really love that, Ravin. So, let me switch gears a bit. I would love for you to talk a little bit about patient advocacy because they do play a huge role in cancer, and they address many barriers. How do you think we should leverage the patient advocacy groups to reduce patient burden and maybe have them really leverage patient advocacies to improve representation in clinical trials? What do we think we can do more? Dr. Ravin Garg: Oh, Pedro, I think they are very critically important. As a clinical oncologist now, and I would say this is for anyone in the field of medicine, you are exactly right. I think patients are bombarded by information. There are a lot of things online, whether it be TikTok, Facebook, Google, Yahoo, and people really just have a lot of information given to them. And some of it is fact driven, and some of it is not, Pedro. And oftentimes, I do think there can be at times a mistrust with some medical personnel. I think we are in an era where we are seeing that to some degree with some attributes of medicine. And I think of it as an opportunity for education for the patient and for myself as a physician. And I think patient advocates, to your point, which was well taken, serve as a bridge to both. And what I mean is that, you know, patient advocates are wonderful. They are, I think, outstanding communicators. They almost are a neutral party, Pedro, where many patients feel that they are an independent source of information that is free of bias, if you will. They are there to provide support, emotional support, scientific support for patients so they can make an informed decision. So, in terms of our practice right now, patient advocates is something that we are evolving in that capacity, I would say, Pedro. I think now more than ever, having more people as bridges of communication with care providers along with patients is of critical importance. And I would venture a guess, and I think this has been published, where patient advocates really can help tremendously in familiarizing patients with trials and what they are all about and maybe clear up some misconceptions of what trials, what the mission of trials are. Because I do think some patients, at least I have had a few over the years, where when they hear the term trial, they almost think they are being experimented upon, when, in point of fact, they could really help advance their care. That messaging along the way for some can may be mixed up a little bit. And so I think patient advocates is a really great way to offer more information for patients with a source they find very independent and trustworthy, if you will. And it can really help expedite, and I think make a more fruitful conversation for care providers, whether academic or community, and they might be more open-minded in terms of enrolling onto a trial. Dr. Pedro Barata: Wonderful. Yes, I agree. I agree with you completely.  So let's focus a little bit now on the folks designing the studies. We usually call them the sponsors. It might be an academic sponsorship, if you will, but we can also have pharma being the sponsor of a study. The angle from an academic design, it is not necessarily the same as what happens when we have pharma. And from that angle, how do you think a more inclusive research can be promoted? Dr. Ravin Garg: Oftentimes with trials, I think keeping them simple, as simple as we can. And what I mean by that is, often times for trials, Pedro, even for care providers who are enrolling, it can be daunting when there are a lot of different things involved, particularly, let's say, for investigator sponsored, which are incredibly brilliant science, incredible, but it can be a little bit daunting for patients and even the referring physician to talk about getting translational specimens, imaging, traveling to certain centers to get scans and biopsies and even different diagnostic testing like PSMA testing for, you know, prostate cancer. And it can, I think, be very intimidating for patients in terms of what might be required of him or her to enter onto a trial. Like, "This is not what I signed up for. This is laborious. This is a full time job for me. Do I have to pay for parking to go to a city? Do I have to pay for these imaging tests? And do I have to stay in a place for my family to enroll onto a trial?" So I think keeping trials as simple as possible, but yet cull the data we need as investigators where we can really advance the care, hopefully get approval for a drug, but also learn more about the medication and how it works for our patients. So I think simplifying language for trial is very important. I know when I have gone over studies for patients, Pedro, if it is a voluminous amount of information, they can right away get very intimidated. "Like, oh my goodness, this is like a term paper for college again," you know? I am joking, but you know, keeping language simplified is very important, I think, number one. And I feel that sometimes when they are asked to do a lot of different diagnostic testing, which is very important for translational work, I 100% understand, but I do think sometimes patients can get a little bit off put, if you will, and frustrated with the whole process of doing it. The second thing for our patients, Pedro, that they have mentioned to us when we put them on trials, not just within our own site but elsewhere, is that it takes a lot of time in terms of collecting information, perhaps a washout period from their last standard of treatment prior to enrollment onto a study. Many patients, Pedro, as you know better than I do, are in maybe crisis in terms of their health and their cancer might be growing, promulgating out of control, and they worry about not being able to expeditiously start onto a treatment, onto a trial. So that can lead to a lot of frustration. And one thing that you brought up, which was outstanding for me, is the enrollment criterion for some of our patients is felt to be somewhat strict. We have had some patients who may have had a remote history of a stage I malignancy that was by all accounts in remission, you know, let's say 4 or 5 years in the past, and the risk of recurrence at this point would be incredibly low, but they may not be able to enter onto a study because of some stringent criterion put forth. And that can be a little bit frustrating. In fact, I have had one or two patients who, as an example, with kidney issues, but the GFR was about 60, like right near a cutoff that oftentimes, as you know, we use where you can get into trial or not. And you know, if they are at 58, as an example, and otherwise they are a picture of health, a great candidate for a trial that will likely advance their care, and if the entry criterion is too stringent, that might be a lost opportunity for all parties involved, all stakeholders, if you will. I do appreciate the criterion for entry onto studies cannot be too liberalized. You have to have a certain baseline, but there is a little bit of a gray area and tension, of sorts, if you will, where the patient has a comorbid illness that is a disqualifying offense, but in practicality, perhaps it shouldn't be, especially if they are motivated and there is an opportunity to really advance their care. We have run into, not often, but sometimes in the past, I should say, where patients have been very off put because we try to get them onto a study and there may have been a particular feature or attribute in their underlying care that they couldn't get onto it. So I think having a little bit more thoughtfulness, perhaps, in terms of entry criterion and practicality, if you will, I think would really help enrollment onto studies. Dr. Pedro Barata: Really well said. Is there anything else that you would like to tell our listeners before we wrap up the podcast today? Dr. Ravin Garg: I would say just macroscopically speaking, it is really an honor to be an oncologist. I think I speak for both of us. Anyone listening who is thinking about the field, it is tremendous. Just the research, the bravery of our patients, and the thoughtfulness of our scientists like Pedro and translationalists and clinical trialists is really awe inspiring. So I have really loved this field. I will say from a trial perspective, we really need to enter as many patients as we can onto trials because the science is so brilliant now, the genomic underpinnings of the tumor, we are making great strides as a team of clinicians and scientists, translationalists. So the more that we can get people onto trials and get approved drugs, it is going to help them out in the end. So I think it is such an important time for all of us to come together as a community, find the best way to help our patients out. And clinical trials have to be at the forefront of how we can continue to advance care for our patients. Dr. Pedro Barata: Yeah, no Ravin, I really agree with you. We really need to increase access to clinical studies, and actually your paper is a great step in that direction by raising awareness, bringing up solutions, and again, collaboration, collaboration, collaboration is really a multidisciplinary effort to accomplish that.  Thank you so much for sharing your fantastic thoughts and insights with us. Dr. Ravin Garg: Thank you, Pedro. I am- you do a wonderful job with these podcasts. I am really honored to meet you and to be part of this. Dr. Pedro Barata: And thank you to our listeners for your time today. I encourage you to check out Dr. Garg's article in the 2025 ASCO Educational Book. We will post a link to the paper in our show notes. And please join us again next month on By the Book for more insights on key advances and innovations that are shaping modern oncology. Thank you for your attention. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:          Dr. Pedro Barata   @PBarataMD    Dr. Ravin Garg Follow ASCO on social media:          @ASCO on X      ASCO on Bluesky     ASCO on Facebook       ASCO on LinkedIn       Disclosures:       Dr. Pedro Barata:   Stock and Other Ownership Interests: Luminate Medical   Honoraria: UroToday   Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon   Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas   Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck    Dr. Ravin Garg: Patents, Royalties, Other Intellectual Property: Creator, editor, and writer of hemeoncquestions.com  

Réécoutez FG mix invite le Buddha Bar Paris avec Ravin du mardi 2 décembre 2025

Caw! Caw! Let The Crow carry you to part two of the High & Low Movie Show's dissection of movies adapting the 90's comic book The Crow! In last week's episode our emo emcee's watched 1994's The Crow, starring Brandon Lee! In this week's episode, the fellah's fast forward to 2024 to watch the Rupert Sander's directed The Crow, starring Bill Skarsgard,  FKA Twigs, and Danny Huston! Wow! A murder of Crows for every occasion! Get social with High & Low!Instagram @HighLowMovieShowThreads @ HighLowMovieShowJoin our Facebook Group The High & Low DungeonBuy Us a Coffee Twitter @HighLowMovieSho

Join Luke, Mitchell, and Vonn as they don their eyeliner and white face paint to embark on a vengeance-filled crusade! This week, they're kicking off their pairing of corvid movies and talking 1994's The Crow. This movie's got a murderer's row of character actors and style coming out the wazoo. While it can't rain all the time, every night is Devil's Night in the High & Low Dungeon!Tune in next week when they round out the category with 2024's The Crow.Get social with High & Low!Instagram @HighLowMovieShowThreads @ HighLowMovieShowJoin our Facebook Group The High & Low DungeonBuy Us a Coffee Twitter @HighLowMovieSho

Gemini 3 is a few days old and the massive leap in performance and model reasoning has big implications for builders: as models begin to self-heal, builders are literally tearing out the functionality they built just months ago... ripping out the defensive coding and reshipping their agent harnesses entirely. Ravin Kumar (Google DeepMind) joins Hugo to breaks down exactly why the rapid evolution of models like Gemini 3 is changing how we build software. They detail the shift from simple tool calling to building reliable "Agent Harnesses", explore the architectural tradeoffs between deterministic workflows and high-agency systems, the nuance of preventing context rot in massive windows, and why proper evaluation infrastructure is the only way to manage the chaos of autonomous loops. They talk through: - The implications of models that can "self-heal" and fix their own code - The two cultures of agents: LLM workflows with a few tools versus when you should unleash high-agency, autonomous systems. - Inside NotebookLM: moving from prototypes to viral production features like Audio Overviews - Why Needle in a Haystack benchmarks often fail to predict real-world performance - How to build agent harnesses that turn model capabilities into product velocity - The shift from measuring latency to managing time-to-compute for reasoning tasks LINKS From Context Engineering to AI Agent Harnesses: The New Software Discipline, a podcast Hugo did with Lance Martin, LangChain (https://high-signal.delphina.ai/episode/context-engineering-to-ai-agent-harnesses-the-new-software-discipline) Context Rot: How Increasing Input Tokens Impacts LLM Performance (https://research.trychroma.com/context-rot) Effective context engineering for AI agents by Anthropic (https://www.anthropic.com/engineering/effective-context-engineering-for-ai-agents) Upcoming Events on Luma (https://lu.ma/calendar/cal-8ImWFDQ3IEIxNWk) Watch the podcast video on YouTube (https://youtu.be/CloimQsQuJM) Join the final cohort of our Building AI Applications course starting Jan 12, 2026 (https://maven.com/hugo-stefan/building-ai-apps-ds-and-swe-from-first-principles?promoCode=vgrav): https://maven.com/hugo-stefan/building-ai-apps-ds-and-swe-from-first-principles?promoCode=vgrav

Réécoutez FG mix invite le Buddha Bar de Paris avec Ravin du mardi 18 novembre 2025

Sources Can kodshim kalim be eaten when there is no altar? Abaye proved from a braita of Rabbi Yishmael that they cannot be eaten. Rabbi Yirmia raised a difficulty against Abaye from a contradiction between braitot, resolving it in a way that one would conclude that kodshim kalim could be eaten even without an altar. However, Ravina provides an alternative resolution to the contradiction, and the Gemara brings another. Rav Huna says in the name of Rav that the altar in the Tabernacle of Shilo was made of stone. However, a difficulty is raised against this from a braita that explains that the fire of Moshe's copper altar continued until the time of Shlomo. They resolve it by saying that Rav Huna held by a different tannaitic opinion. Alternatively, one can explain that the fire could have still been on Moshe's altar, even though they were using the stone altar. If so, what was the fire used for? The Gemara suggests two possible answers. A Mishna is brought which says that the altar in the time of the Second Temple was expanded to be larger than the one in the First Temple, from 28x28 cubits to 32x32. Why? Rav Yosef suggests it was expanded as they needed more space. Ravin explained it based on a Mishna in Middot that described the addition of the shitin, two holes that were added for the libations.

Sources Can kodshim kalim be eaten when there is no altar? Abaye proved from a braita of Rabbi Yishmael that they cannot be eaten. Rabbi Yirmia raised a difficulty against Abaye from a contradiction between braitot, resolving it in a way that one would conclude that kodshim kalim could be eaten even without an altar. However, Ravina provides an alternative resolution to the contradiction, and the Gemara brings another. Rav Huna says in the name of Rav that the altar in the Tabernacle of Shilo was made of stone. However, a difficulty is raised against this from a braita that explains that the fire of Moshe's copper altar continued until the time of Shlomo. They resolve it by saying that Rav Huna held by a different tannaitic opinion. Alternatively, one can explain that the fire could have still been on Moshe's altar, even though they were using the stone altar. If so, what was the fire used for? The Gemara suggests two possible answers. A Mishna is brought which says that the altar in the time of the Second Temple was expanded to be larger than the one in the First Temple, from 28x28 cubits to 32x32. Why? Rav Yosef suggests it was expanded as they needed more space. Ravin explained it based on a Mishna in Middot that described the addition of the shitin, two holes that were added for the libations.

Réécoutez FG mix invite le Buddha Bar de Paris avec Ravin du mardi 11 novembre 2025

Is multiculturalism a confused concept? Does belonging require assimilation? And when does the real work of inclusion begin? SBS Hindi sat down with Ravin Ramachandran Nair, a public servant working with multicultural communities in Cairns, to unpack these questions. Join us as he shares his insights on cultural enrichment, intentional leadership, and what it truly means to belong in a diverse Australia.

Réécoutez FG mix invite le Buddha Bar de Paris avec Ravin du mardi 28 octobre 2025

Study Guide Ulla said in the name of Reish Lakish that even if an impure person inserts only a small part of their body into the Azara (Temple courtyard), it is forbidden. Rav Hoshaya challenges this ruling based on a case involving a leper who experienced a seminal emission on the eve of Passover. Despite his impurity, he is permitted to proceed with the purification process, which requires partial entry into the Azara. Ulla resolves this difficulty. A braita is brought in support of Ulla’s statement, discussing the smicha (laying of hands) on the guilt offering of a leper, which is performed outside the Azara. The implication is that if partial entry were permitted, the leper could simply insert his hands into the Azara to perform the smicha. Rav Yosef rejects this support, and there are two distinct versions of how he rejects this. A difficulty is raised against the content of the braita: if the guilt offering requires smicha by Torah law, and if smicha must be performed immediately prior to slaughtering, then it should be permitted to perform the smicha inside the Azara. Rav Ada bar Matna resolves this challenge, though there are differing accounts of how he does so. Ravina and Ravin each offer alternative resolutions to the difficulty with Ulla’s statement. Ravina maintains that partial entry into the Azara is prohibited only by a penalty of lashes, without the more severe punishment of karet. Ravin, on the other hand, argues that Ulla’s citation of Reish Lakish was inaccurate. According to Ravin, Reish Lakish was referring to lashes incurred by one who touches sacrificial items (kodashim), not one who enters the Azara. This leads to a broader debate between Reish Lakish and Rabbi Yochanan regarding the interpretation of the verse “do not touch kodesh.” Reish Lakish understands it as referring to sacrificial items, while Rabbi Yochanan interprets it as referring to teruma. A question arises: how can Reish Lakish derive both the prohibition to touch and the prohibition to eat sacrificial items from the same verse, as he does in a separate debate with Rabbi Yochanan? The Gemara addresses this and explains how both prohibitions can be learned from the same textual source.  

Study Guide Ulla said in the name of Reish Lakish that even if an impure person inserts only a small part of their body into the Azara (Temple courtyard), it is forbidden. Rav Hoshaya challenges this ruling based on a case involving a leper who experienced a seminal emission on the eve of Passover. Despite his impurity, he is permitted to proceed with the purification process, which requires partial entry into the Azara. Ulla resolves this difficulty. A braita is brought in support of Ulla’s statement, discussing the smicha (laying of hands) on the guilt offering of a leper, which is performed outside the Azara. The implication is that if partial entry were permitted, the leper could simply insert his hands into the Azara to perform the smicha. Rav Yosef rejects this support, and there are two distinct versions of how he rejects this. A difficulty is raised against the content of the braita: if the guilt offering requires smicha by Torah law, and if smicha must be performed immediately prior to slaughtering, then it should be permitted to perform the smicha inside the Azara. Rav Ada bar Matna resolves this challenge, though there are differing accounts of how he does so. Ravina and Ravin each offer alternative resolutions to the difficulty with Ulla’s statement. Ravina maintains that partial entry into the Azara is prohibited only by a penalty of lashes, without the more severe punishment of karet. Ravin, on the other hand, argues that Ulla’s citation of Reish Lakish was inaccurate. According to Ravin, Reish Lakish was referring to lashes incurred by one who touches sacrificial items (kodashim), not one who enters the Azara. This leads to a broader debate between Reish Lakish and Rabbi Yochanan regarding the interpretation of the verse “do not touch kodesh.” Reish Lakish understands it as referring to sacrificial items, while Rabbi Yochanan interprets it as referring to teruma. A question arises: how can Reish Lakish derive both the prohibition to touch and the prohibition to eat sacrificial items from the same verse, as he does in a separate debate with Rabbi Yochanan? The Gemara addresses this and explains how both prohibitions can be learned from the same textual source.  

Réécoutez FG mix invite le Buddha Bar de Paris avec Ravin du mardi 14 octobre 2025

We're in an era where everyone's talking about AI, but few are actually getting value from it. In this episode, futurist and author Ravin Jesuthasan joins host David Rice to unpack why the ROI of AI is still so elusive — and why most organizations are looking at it backwards.Ravin argues that the problem isn't technological; it's human. Companies are rushing to deploy tools before they rethink the work itself. He explains how leaders can shift from a tech-first to a work-first mindset, what it really means to be AI fluent, and why the job-based identity that defined the past 150 years of work is quietly crumbling.If you're an HR leader, executive, or strategist trying to navigate AI adoption without losing the human center of work, this conversation will help you see what transformation actually looks like — and where to start.Related Links:Join the People Managing People community forumSubscribe to the newsletter to get our latest articles and podcastsConnect with Ravin on LinkedInCheck out Mercer and Ravin's websiteSupport the show

Réécoutez FG mix invite le Buddha Bar de Paris avec Ravin du mardi 30 septembre 2025

This episode dissects Alexandre Aja's remake of The Hills Have Eyes, exploring what makes it both faithful to and different from Wes Craven's 1977 original. We discuss the updated setting, the intensified atmosphere, and the new practical effects that bring the ghastly inhabitants to life, courtesy of talent like Greg Nicotero and his team. Listen as we break down standout performances from Aaron Stanford, Kathleen Quinlan, Vinessa Shaw, and Emilie de Ravin, and how actors such as Dan Byrd, Robert Joy, and Billy Drago contribute to the terrifying dynamic. Joining in for this spooky good chat are Alex and Dean of the Return Revenge Resurrection podcast and they're ready to go all in on one of the most underrated horror remakes to emerge out of the craze that began with 2003's The Texas Chainsaw Massacre. Get ready for a special look at behind-the-scenes decisions, scares, and the film's lasting impact on horror remakes.Links For Guests: Return Revenge ResurrectionWhere To Watch The Hills Have Eyes (2006)

Réécoutez l'Happy Hour DJ de Ravin du mardi 23 septembre 2025

I am liking the R29X more and more as I get used to it. It lacks the smooth shooting of the SWAT X1, but gains 65 feet per second or more, and also is decockable. If I were to hunt with it, what would that look like? What are my hunting plans for the fall of 2025? I talk about that in this episode of Talking With Bunjie!

The Mishna discusses the laws of nullification regarding yayin nesech (wine used for idolatry) that becomes mixed with permitted wine. It distinguishes between wine mixed with wine (min b’minu—same substance), which is forbidden in any amount, and wine mixed with water (min b’she’eino mino—different substance), which is prohibited only if it imparts taste. Rav Dimi quotes Rabbi Yochanan as saying that if one pours yayin nesech from a barrel into a pit of kosher wine, each drop is immediately nullified upon contact. The Gemara raises three challenges to Rav Dimi’s interpretation based on the Mishna, and resolves them by reinterpreting the cases in the Mishna. Rav Yitzchak bar Yosef offers a narrower understanding of Rabbi Yochanan’s ruling—limiting it to pouring from a jug into a barrel, but not from a barrel into a pit. Ravin also transmits a halakha in Rabbi Yochanan’s name regarding a mixture that includes a forbidden item combined with both a similar and a different substance. In such a case, the forbidden item is nullified by the different substance (e.g., yayin nesech mixed with wine and water), while the similar substance is viewed as if it is not there. Rav Shmuel bar Yehuda also quotes Rabbi Yochanan, but there are two versions of his statement. In one version, he disagrees with Ravin and limits the ruling to cases where the different substance was present first. In the other version, his comment refers to the Mishna, and he actually agrees with Ravin. A debate between Chizkiya and Rabbi Yochanan also concerns a case where a forbidden item is mixed with both a similar and a different substance. What is the underlying basis of their disagreement? Rav and Shmuel dispute the position of Rabbi Yochanan and Reish Lakish regarding whether the distinction between mixtures of the same type and mixtures of different types applies universally to all prohibited items, or only to yayin nesech and tevel (untithed produce). The Gemara explains why the rabbis would have adopted a stricter approach with those two prohibitions.

The Mishna discusses the laws of nullification regarding yayin nesech (wine used for idolatry) that becomes mixed with permitted wine. It distinguishes between wine mixed with wine (min b’minu—same substance), which is forbidden in any amount, and wine mixed with water (min b’she’eino mino—different substance), which is prohibited only if it imparts taste. Rav Dimi quotes Rabbi Yochanan as saying that if one pours yayin nesech from a barrel into a pit of kosher wine, each drop is immediately nullified upon contact. The Gemara raises three challenges to Rav Dimi’s interpretation based on the Mishna, and resolves them by reinterpreting the cases in the Mishna. Rav Yitzchak bar Yosef offers a narrower understanding of Rabbi Yochanan’s ruling—limiting it to pouring from a jug into a barrel, but not from a barrel into a pit. Ravin also transmits a halakha in Rabbi Yochanan’s name regarding a mixture that includes a forbidden item combined with both a similar and a different substance. In such a case, the forbidden item is nullified by the different substance (e.g., yayin nesech mixed with wine and water), while the similar substance is viewed as if it is not there. Rav Shmuel bar Yehuda also quotes Rabbi Yochanan, but there are two versions of his statement. In one version, he disagrees with Ravin and limits the ruling to cases where the different substance was present first. In the other version, his comment refers to the Mishna, and he actually agrees with Ravin. A debate between Chizkiya and Rabbi Yochanan also concerns a case where a forbidden item is mixed with both a similar and a different substance. What is the underlying basis of their disagreement? Rav and Shmuel dispute the position of Rabbi Yochanan and Reish Lakish regarding whether the distinction between mixtures of the same type and mixtures of different types applies universally to all prohibited items, or only to yayin nesech and tevel (untithed produce). The Gemara explains why the rabbis would have adopted a stricter approach with those two prohibitions.

I've had the Black Widow for a year. Here's a look at some predictions I made and how they panned out!

In this episode of Gun Talk Hunt, host KJ sits down with John Hernandez from Ravin Crossbows, to explore the groundbreaking R18 vertical crossbow and why it's a game-changer for hunters of all levels.Whether you're a traditional vertical bow shooter, a gun hunter looking to extend your season, or a parent introducing kids to archery, this deep dive into crossbow innovation has something for you. John shares how Ravin Crossbows evolved the market, why the R18 is more than just a crossbow, and how modern design can lead to quicker success in the field.This Gun Talk Hunt is brought to you by Timney Triggers, First Person Defender, Savage Arms, and Remington Ammunition.NEXT WEEK check out Gun Talk Hunt on a NEW YouTube channel! Find it here: https://www.youtube.com/@guntalkhuntGet 5% off any order at Optics Planet with code GUNTALK.Check out the NEW First Person Defender YouTube channel HERE.About Gun Talk HuntGun Talk Media's Gun Talk Hunt, with Kevin “KJ” Jarnagin, pairs decades of experience with today's latest tools and technology to help you succeed in the field. Whether it runs or flies - no matter what game you pursue - Gun Talk Hunt is a multi-platform podcast that gives today's hunters a voice in the digital world.For more content from Gun Talk Media, visit guntalk.com or subscribe on YouTube, Rumble, Facebook, Instagram, and X. Catch First Person Defender on the new Official FPD YouTube channel. Listen to all Gun Talk Podcasts with Spreaker, iHeart, Apple Podcasts, Spotify or wherever you find podcasts.Copyright ©2025 Freefire Media, LLCGun Talk Hunt 08.16.25Become a supporter of this podcast: https://www.spreaker.com/podcast/gun-talk--6185159/support.

While much of the AI world chases ever-larger models, Ravin Kumar (Google DeepMind) and his team build across the size spectrum, from billions of parameters down to this week's release: Gemma 270M, the smallest member yet of the Gemma 3 open-weight family. At just 270 million parameters, a quarter the size of Gemma 1B, it's designed for speed, efficiency, and fine-tuning. We explore what makes 270M special, where it fits alongside its billion-parameter siblings, and why you might reach for it in production even if you think “small” means “just for experiments.” We talk through: - Where 270M fits into the Gemma 3 lineup — and why it exists - On-device use cases where latency, privacy, and efficiency matter - How smaller models open up rapid, targeted fine-tuning - Running multiple models in parallel without heavyweight hardware - Why “small” models might drive the next big wave of AI adoption If you've ever wondered what you'd do with a model this size (or how to squeeze the most out of it) this episode will show you how small can punch far above its weight. LINKS Introducing Gemma 3 270M: The compact model for hyper-efficient AI (Google Developer Blog) (https://developers.googleblog.com/en/introducing-gemma-3-270m/) Full Model Fine-Tune Guide using Hugging Face Transformers (https://ai.google.dev/gemma/docs/core/huggingface_text_full_finetune) The Gemma 270M model on HuggingFace (https://huggingface.co/google/gemma-3-270m) The Gemma 270M model on Ollama (https://ollama.com/library/gemma3:270m) Building AI Agents with Gemma 3, a workshop with Ravin and Hugo (https://www.youtube.com/live/-IWstEStqok) (Code here (https://github.com/canyon289/ai_agent_basics)) From Images to Agents: Building and Evaluating Multimodal AI Workflows, a workshop with Ravin and Hugo (https://www.youtube.com/live/FNlM7lSt8Uk)(Code here (https://github.com/canyon289/ai_image_agent)) Evaluating AI Agents: From Demos to Dependability, an upcoming workshop with Ravin and Hugo (https://lu.ma/ezgny3dl) Upcoming Events on Luma (https://lu.ma/calendar/cal-8ImWFDQ3IEIxNWk) Watch the podcast video on YouTube (https://youtu.be/VZDw6C2A_8E)

For The Other Side NDE Videos Visit ▶️ youtube.com/@TheOtherSideNDEYT Purchase our book on Amazon

Ron Schara and his companion Ravin the black lab celebrated 30 years of "Minnesota Bound" television. Ron shares some of the stories from how it all began and what carried it for it's continuing incredible run. See omnystudio.com/listener for privacy information.

Is your workforce strategy stuck in the past? As AI accelerates and traditional job structures show their age, more companies are asking a fundamental question: Are we organising work the right way? Which is why, in this episode of the Digital HR Leaders podcast, David and his guests explore why skills-based workforce planning has surged to the top of the HR agenda - and what leading companies are doing to turn intent into action. Joining David are Ravin Jesuthasan, Senior Partner and Global Leader for Transformation Services at Mercer, and co-author of The Skills-Powered Organization, and Brian Fisher, Global Solutions Lead for Skills, Jobs and Careers at Mercer, and co-author of Mercer's Skills Snapshot Survey. What you'll learn in this episode: Why jobs are no longer the ideal unit for workforce planning, and why skills are taking centre stage How to align mindset, skillset and toolset to drive lasting transformation The role of pilots and internal marketplaces in delivering measurable business impact What AI is changing about the definition, demand and shelf life of skills The three core capabilities every organisation must build to sustain a skills-powered strategy How leading companies are connecting skills to ROI, workforce agility, and employee growth This episode is sponsored by Mercer. To thrive in an AI-augmented world, organisations must rethink how work gets done. Mercer's Work Design solution uses AI to deconstruct jobs, redeploy tasks, and redesign work for greater agility, productivity, and impact. Unlock your team's full potential. Learn more at mercer.com/wfdemo Links to resources discussed in the episode: Work Without Jobs The Skills-Powered Organisation The Global Skills Technology and Adoption Survey Report The 2024/2025 Skills Snapshot Survey report Hosted on Acast. See acast.com/privacy for more information.

Waardeer je onze video's? Steun dan Café Weltschmerz, het podium voor het vrije woord: https://www.cafeweltschmerz.nl/doneren/Ravin en Shohreh spreken zich uit over de situatie in Iran. Dit wordt ze niet in dank afgenomen. Inmiddels hebben beiden politiebescherming nodig omdat de bedreigingen blijven toenemen. In het geval van Shohreh lijkt die dreiging vooral uit de achterban van Weltschmerz te komen. In dit gesprek gaan Ravin en Shohreh in op deze bedreigingen en delen hun mening over de situatie in Iran. Ongeacht hoe je over de verschillende conflicten in het Midden Oosten denkt, een aanrader om met een open hart te luisteren en naar aanleiding daarvan jouw eigen mening te vormen.---Deze video is geproduceerd door Café Weltschmerz. Café Weltschmerz gelooft in de kracht van het gesprek en zendt interviews uit over actuele maatschappelijke thema's. Wij bieden een hoogwaardig alternatief voor de mainstream media. Café Weltschmerz is onafhankelijk en niet verbonden aan politieke, religieuze of commerciële partijen.Wil je meer video's bekijken en op de hoogte blijven via onze nieuwsbrief? Ga dan naar: https://www.cafeweltschmerz.nl/videos/Wil je op de hoogte worden gebracht van onze nieuwe video's? Klik dan op deze link: https://bit.ly/3XweTO0

When was the last time your organization redesigned work, not just reorganized jobs? Ravin Jesuthasan, bestselling author and global leader for transformation services at Mercer, explains why work redesign is the missing foundation for successful transformation. Drawing from his books "Work Without Jobs" and "The Skills-Powered Organization," Ravin shares how deconstructing work into its core tasks and redeploying them efficiently led to extraordinary results—like an oil company cutting performance variance from 35% to 2.3% without layoffs. Discover why "fixed, flex, and flow" models are replacing traditional jobs, how resistance to change plummets when employees help redesign their own work, and why transformations should never be "one and done."----Connect with:⁠⁠⁠⁠⁠⁠⁠⁠⁠Nellie Wartoft⁠⁠⁠⁠⁠⁠⁠⁠⁠CEO of ⁠⁠⁠⁠⁠⁠⁠⁠⁠Tigerhall⁠⁠⁠⁠⁠⁠⁠⁠⁠Chair of the ⁠⁠⁠⁠⁠⁠⁠⁠⁠Executive Council for Leading Change (ECLC)⁠⁠⁠⁠⁠⁠⁠⁠⁠nellie@tigerhall.com ----00.00 - Introduction 01:30 - Why work redesign is pivotal to organizational transformation03:45 - The three steps of work redesign: deconstruction, redeployment, reconstruction05:20 - How job architecture fits into the work redesign approach07:10 - Signs that outdated work structures are blocking transformation efforts09:15 - Why tech-forward approaches fail compared to work-backwards perspectives11:30 - Case study: How an oil company transformed operations without layoffs14:45 - The critical role of leadership in connecting work redesign to transformation goals16:20 - How work redesign reduces resistance to change19:40 - Moving from employment to employability: upskilling, reskilling, and outskilling22:15 - The three models of work: fixed, flexible, and flow24:30 - How internal talent marketplaces and "flow to work" models dramatically increase productivity27:15 - Building leadership buy-in for flexible work allocation29:35 - Final thoughts: Transformation is never "one and done"----Breathe by RYGO | https://soundcloud.com/francesco-rigolonEverything You Need Is By Your Side by Vlad Gluschenko |Music promoted by https://www.free-stock-music.comCreative Commons / Attribution 3.0 Unported License (CC BY 3.0)https://creativecommons.org/licenses/by/3.0/deed.en_US

Drawing on their professional and academic experience, Ravin Jesuthasan and John Boudreau argue the current work “operating system” is increasingly unable to meet the needs of employees and employers. They join the Talent Angle to discuss their new book, Work Without Jobs: How to Reboot Your Organization's Work Operating System, and the opportunities for HR to shape a new vision for the future of work. Jesuthasan and Boudreau propose a new work “operating system” based on deconstructed work and deconstructed talent that would ultimately lead to a more human-centric approach to work. In their new vision for the future of work, they emphasize the importance of developing capabilities that will enable organizations to redesign and reinvent work and the employee experience. Ravin Jesuthasan is the global leader of Mercer's Transformation Services business.  He has led multiple research efforts on the global workforce, the emerging digital economy, the rise of artificial intelligence and the transformation of work. Ravin has led numerous research projects for the World Economic Forum including many of its ground-breaking studies on the transformation of work and the global workforce. He is a regular participant and presenter at the World Economic Forum's annual meeting in Davos and is a member of the forum's Steering Committee on Work and Employment. He is the author of the books Transformative HR (Wiley, 2012), Lead The Work: Navigating a World Beyond Employment (Wiley 2015), Reinventing Jobs: A 4-Step Approach to Applying Automation to Work (HBR Press, 2018) and the Wall Street Journal bestseller; Work Without Jobs: How to Reboot Your Organization's Work Operating System (MIT Press, 2022). Dr. John Boudreau is recognized worldwide as a leading evidence-based visionary on the future of work and organization. Dr. Boudreau is Professor Emeritus of Management and Organization and a Senior Research Scientist with the Center for Effective Organizations, at the Marshall School of Business, University of Southern California. For 40 years, he has conducted breakthrough research on the bridge between work, superior human capital, leadership and sustainable competitive advantage.  His research addresses the future of work and the global HR profession, work automation, HR measurement and analytics, decision-based HR, executive mobility, HR information systems and organizational staffing and development.  Dr. Boudreau helped to establish and then directed the Center for Advanced Human Resource Studies (CAHRS) at Cornell University, where he was a professor for more than 20 years Peter Aykens is chief of research in Gartner's human resources practice. He is responsible for defining research coverage within the practice and building and leading research teams that address clients' key initiatives. In prior roles at the firm, he spent over 25 years leading research teams focused on banking and financial services strategy, producing numerous studies that addressed business strategy, channels, marketing, customer experience and product issues in financial services. He holds a bachelor's degree in political science from St. Olaf College; a master's degree in international politics from the University College of Wales, Aberystwyth (now known as Aberystwyth University); and a master's degree and a doctorate in political science from Brown University.

In this mashup episode, five bold voices—Russ Perry, Paul ter Wal, Ravin S. Papiah, Dr. Rob McCleland, and host Denis Gianoutsos—share how leadership is evolving in an era of uncertainty, autonomy, and authenticity.From redefining power and trust to embracing uncomfortable transitions, these leaders reveal what it takes to stay relevant, empower others, and lead with clarity in today's ever-shifting world.If you're ready to challenge the traditional leadership model, this episode will spark fresh thinking and maybe even a transformation.EP110 - Russ Perry: Embracing the Innovation CurveLeaders must see change as a job requirement, not an inconvenienceTechnology should excite leaders, not threaten them“If you're not changing, you're becoming irrelevant.”EP111 - Paul ter Wal: From Hierarchies to Human-Centered LeadershipLeadership is moving from control to facilitationProfessionals don't need micromanagement, they need trust and space“Transparency + truth = trust”EP113- Ravin S. Papiah: Leadership Belongs to EveryoneTrue leadership starts with self-leadershipPower should serve, not controlA shift is happening—people are reclaiming their voice and accountabilityEP114 - Dr. Rob McCleland: Lead with Truth and LoveLeadership today demands cross-generational empathyPersonal failure can fuel transformational leadership“The world will never change this slowly again.”Denis Gianoutsos: Personal Journeys as CatalystsLeadership transformation often starts in discomfortCourage to walk away from what's familiar is the start of true leadershipReflecting on purpose and the future brings deeper clarityKey Quotes: "The ability to change as a leader is the most critical function." – Russ Perry "Give people trust upfront. That's where responsibility grows." – Paul ter Wal "Leadership is not just for those in power—everyone leads." – Ravin S. Papiah "Truth and love are the foundations of leadership that lasts." – Dr. Rob McCleland "You'll never change slower than you are today." – Dr. Rob McClelandThe 10 Proven Ways to Lead and Thrive in Today's World - FREE Executive Guide Download https://crm.leadingchangepartners.com/10-ways-to-lead Connect with Denis: Email: denis@leadingchangepartners.comWebsite: www.LeadingChangePartners.com Facebook: https://www.facebook.com/denisgianoutsos LinkedIn: https://www.linkedin.com/in/denisgianoutsos/ Instagram: https://www.instagram.com/leadershipischanging/ YouTube Channel: https://www.youtube.com/@DenisGianoutsos

About our guest … Leon Ravin, MD is currently serving in the position ofStatewide Psychiatric Medical Director for the Division of Public and BehavioralHealth, DHHS, State of Nevada. In addition to Dr. Raven being a board-certifiedgeneral adult and forensic psychiatrist Dr. Raven also serves as a member of theStatewide School Safety Task Force for the State of Nevada and a member ofthe Executive Committee of the Medical Directors Council of the NationalAssociation of State Mental Health Program Directors. Dr. Ravin served for fouryears as a member of the LAI work group for SMI Adviser, an APA and SAMHSAinitiative that offers researched, vetted and verified guidance to the bestresources on SMI. Since 2010 Dr. Ravin has been a member of the ConferenceCommittee for the Annual National Psychopharmacology Update, the largestpsychopharmacology conference in the United States. Additionally, since 2013Dr. Ravin has been one for the lead trainers for the Crisis Intervention Team (CIT)training for the Las Vegas Metropolitan Police Department.

Kate Bravery, Global Leader of Talent Advisory at Mercer, is joined by Ravin Jesuthasan, Mercer's Global Transformation Leader, and Tanuj Kapilashrami, Chief Strategy and People Officer at Standard Chartered Bank, to discuss The Skills-Powered Organization: The Journey to the Next-Generation Enterprise, their recently released book.Together, they explore the concept of skills-powered organizations and their transformative potential in the workplace. They discuss the shift from traditional job structures to a focus on skills as the currency of work and highlight the need for organizations to adopt a systemic approach to talent management that aligns with business strategy. Tanuj shares insights from her experience at Standard Chartered Bank, detailing how they integrated skills development into their growth agenda and engaged employees in the transformation process. Ravin stresses the importance of understanding the economic implications of skills-powered practices and the need for organizations to be agile in responding to changing work demands.

Réécoutez FG mix invite le Buddha Bar de Paris avec Ravin du mardi 15 avril 2025

Réécoutez FG mix invite le Buddha Bar de Paris avec Ravin du mardi 15 avril 2025

Today's daf is sponsored by Avi Yonitzman for finishing Mashechet Shekalim. "I've now closed the gap from Berakhot to Shekalim and may we be zoche to finishing the 14th cycle together." Today's daf is sponsored for a refuah shleima to Pesha Etel bat Sara. If a man engages in intercourse with a gentile woman, a zealot can kill him if they are still engaged in the act. Rav Kahana asked Rav what punishment is given if a zealot did not kill him at the time of the act. Rav did not remember, but Rav Kahana heard a verse from Malachi 2:11 in a dream and when he recounted it to Rav, Rav remembered that the person gets karet, death by the hands of God. Rabbi Chiya bar Avuya taught that one who engages in relations with a gentile woman is as if he married an idol, as he derived from the verse Rav Kahana heard in his dream. He also brought a story about the skull of Yehoyakim that would not be buried and was subsequently burned, which he derived from a verse in Yirmiyahi 22:19. The Hasmonean court made a decree that one who engages in relations with a gentile woman could be liable for four violations. Rav Dimi and Ravin disagreed about which four. Both Rav Chisda and Rabbi Yochanan explained that even though a zealot can kill a man who engages in relations with a gentile woman, if one consults with the court about it, the court will not tell the person to kill. The person is also not permitted to kill once the couple is no longer engaged in relations. And if the man engaged in relations kills the zealot, he is not liable as the zealot is considered a rodef. The Gemara recounts the story of Pinchas killing Zimri and Cosbi and elaborates on the details provided in the Torah. Rav Acha asked Rav Sheshet is a kohen who serves while impure punished by death by the hands of God? Can the answer be found in our Mishna?  

Today's daf is sponsored by Avi Yonitzman for finishing Mashechet Shekalim. "I've now closed the gap from Berakhot to Shekalim and may we be zoche to finishing the 14th cycle together." Today's daf is sponsored for a refuah shleima to Pesha Etel bat Sara. If a man engages in intercourse with a gentile woman, a zealot can kill him if they are still engaged in the act. Rav Kahana asked Rav what punishment is given if a zealot did not kill him at the time of the act. Rav did not remember, but Rav Kahana heard a verse from Malachi 2:11 in a dream and when he recounted it to Rav, Rav remembered that the person gets karet, death by the hands of God. Rabbi Chiya bar Avuya taught that one who engages in relations with a gentile woman is as if he married an idol, as he derived from the verse Rav Kahana heard in his dream. He also brought a story about the skull of Yehoyakim that would not be buried and was subsequently burned, which he derived from a verse in Yirmiyahi 22:19. The Hasmonean court made a decree that one who engages in relations with a gentile woman could be liable for four violations. Rav Dimi and Ravin disagreed about which four. Both Rav Chisda and Rabbi Yochanan explained that even though a zealot can kill a man who engages in relations with a gentile woman, if one consults with the court about it, the court will not tell the person to kill. The person is also not permitted to kill once the couple is no longer engaged in relations. And if the man engaged in relations kills the zealot, he is not liable as the zealot is considered a rodef. The Gemara recounts the story of Pinchas killing Zimri and Cosbi and elaborates on the details provided in the Torah. Rav Acha asked Rav Sheshet is a kohen who serves while impure punished by death by the hands of God? Can the answer be found in our Mishna?  

In this episode of The Plastic Surgery Revolution, Dr. Steven Davis sits down with Dr. Ravin Patel, a primary care and sports medicine physician with a passion for health, wellness, and performance optimization. Together, they explore the intersection of sports medicine, staying healthy while working out, and the importance of balancing GLP-1 medications with a well-rounded lifestyle. Episode Highlights: Dr. Patel's Journey in Sports Medicine Dr. Patel shares his path from completing a seven-year accelerated medical program at NOVA Southeastern University to becoming a team physician for multiple Division I sports teams during his fellowship at Penn State University. His experiences working with football, basketball, and hockey teams have given him unique insights into injury prevention, recovery, and peak performance. The Science Behind Staying Healthy While Working Out Dr. Davis and Dr. Patel discuss how to train effectively while minimizing injury risks. Whether you're a weekend warrior or a serious athlete, they cover key strategies for maintaining joint health, muscle recovery, and overall fitness longevity. The Role of GLP-1 Medications in Health and Wellness With GLP-1 medications becoming increasingly popular for weight management, Dr. Patel explains how these medications can be incorporated into a healthy, active lifestyle. The conversation highlights the importance of nutrition, exercise, and medical supervision to maximize benefits while maintaining muscle mass and metabolic health. Bridging the Gap Between Medicine, Fitness, and Aesthetic Goals Both doctors emphasize a holistic approach to wellness, where sports medicine, fitness, and aesthetic goals align. From injury prevention to body composition management, they offer insights into achieving long-term health and confidence. If you're interested in sports medicine, fitness longevity, or how modern weight loss treatments fit into a healthy lifestyle, this conversation is a must-listen. Dr. Davis and Dr. Patel break down complex topics in an engaging and accessible way, offering real-world insights from two experts who understand both medicine and aesthetics. Tune in to The Plastic Surgery Revolution to hear this insightful discussion with Dr. Ravin Patel. Listen, share, and subscribe wherever you get your podcasts to stay up to date with the latest in plastic surgery, aesthetics, and wellness.

In this episode of the AI Evolution podcast, Adriana O'Kain and Ravin Jesuthasan discuss the transformative impact of AI on the workforce. They explore the shift from a technology-focused approach to a work-backwards strategy, emphasizing the importance of redesigning work to capture ROI. The conversation highlights the evolving role of HR in integrating AI solutions and the necessary mindset and skills for success in an AI-augmented world. Ravin shares insights on practical examples and the critical need for organizations to adapt to the changing landscape of work.Takeaways Organizations must adopt a work-backwards approach to AI integration. Redesigning work can lead to significant ROI improvements. HR plays a crucial role in orchestrating AI and human collaboration. Mindset shifts are essential for embracing AI technologies. Skills development is critical for navigating the AI landscape. AI should be seen as a partner in the workforce, not just a tool. Continuous learning and adaptation are necessary in the AI era. Understanding elemental tasks is key to effective AI deployment. Organizations need to decouple growth from resource intensity. Curiosity and openness to change are vital for success.

Talking music, who's inspiring us lately, aliens, politics, and more with The Goat Show guys. peoplewelovepodcast.com, instagram.com/peoplewelovepodcast, instagram.com/adamchoit, twitter.com/adamchoit

Tony chats with Eliron Ekstein, CEO at Ravin.AI, they have built a platform that combines AI-assisted image capture technology that helps insureds get the right photos of their auto accident. It also helps prevent fraud. The platform uses AI to assess the repairs needed for that vehicle.Eliron Ekstein: https://www.linkedin.com/in/eliron-ekstein-41609819/Ravin: https://Ravin.aiVideo Version: https://youtu.be/cj1tJwA3Hfo

Imagine a workplace where your skills – not your job title – define your value. What if the way we've understood work for decades is about to be completely transformed? In this episode, Kevin is joined by Ravin Jesuthasan to discuss how the rise of skills-based organizations is reshaping work, talent management, and leadership. Ravin shares a case for why organizations must move beyond traditional job structures and adopt a new model where skills are the currency of work. He also discusses how AI is driving this transformation, both as a disruptor and as a tool. AI offers a pathway to match skills with opportunities at scale. Ravin also highlights the importance of combining technical skills with human (enabling) skills, the role of leaders in recognizing potential, and how emerging tools can help individuals navigate their career paths in meaningful ways. Listen For 00:00 Introduction 00:29 Podcast Overview and Sponsor Introduction 01:18 Book Promotion: Flexible Leadership 02:08 Guest Introduction: Ravin Jesuthasan 03:05 Genesis of The Skills Powered Organization 06:31 Challenges of Transitioning to a Skills-Powered Organization 09:11 Why Now? The Case for Skills-Based Work 12:44 Drivers of Change in a Complex World 17:05 The Role of Skills and Passion in Work Design 19:02 Essential Leadership Skills for a Skills-Powered Organization 22:20 Challenges of Shifting from Jobs to Skills 24:22 How AI Enables the Transformation to Skills-Based Work 28:01 Unilever's Example of a Skills-Based Marketplace 30:04 Personal Insights: Ravin's Hobbies and Interests 31:26 Current Reads and Closing Remarks Meet Ravin Ravin's Story: Ravin Jesuthasan is the author of The Skills-Powered Organization: The Journey to the Next-Generation Enterprise (October 1, 2024; The MIT Press) with Tanuj Kapilashrami, the Wall Street Journal Bestseller Work without Jobs (MIT Press), as well as Transformative HR, Lead the Work, and Reinventing Jobs. He is a recognized futurist and authority on the future of work, human capital, and AI, is Senior Partner and Global Leader for Transformation Services at Mercer. He is a member of the World Economic Forum's Future Skills Executive Board and Global Foresight Network. He is a member of the faculty at Caltech. https://www.ravinjesuthasan.com/ https://skillspoweredorganization.com/ https://x.com/RavinJesuthasan https://www.linkedin.com/in/ravinjesuthasan/   This Episode is brought to you by... Flexible Leadership is every leader's guide to greater success in a world of increasing complexity and chaos.  Book Recommendations The Skills-Powered Organization: The Journey to the Next-Generation Enterprise by Ravin Jesuthasan, Tanuj Kapilashrami  War by Bob Woodward Like this? How the Future Works with Brian Elliott The Skills You Need to Lead in Business Today with Nathan Kracklauer Podcast Better! Sign up with Libsyn and get up to 2 months free! Use promo code: RLP   Leave a Review If you liked this conversation, we'd be thrilled if you'd let others know by leaving a review on Apple Podcasts. Here's a quick guide for posting a review. Review on Apple: https://remarkablepodcast.com/itunes    Join Our Community If you want to view our live podcast episodes, hear about new releases, or chat with others who enjoy this podcast join one of our communities below. Join the Facebook Group Join the LinkedIn Group  

Ravin Jesuthasan is a global thought leader, futurist, and bestselling author on the future of work. He has authored six books and over 200 articles including 15 for the Harvard Business Review and the Sloan Management Review. He is a regular presenter at the World Economic Forum and has been featured extensively by CNN, BBC, The Wall Street Journal, CNBC, and Fortune, among others. Ravin is also featured prominently on PBS's widely acclaimed documentary series The Future of Work. He is a frequent guest lecturer at universities around the world including Caltech, Oxford, Northwestern, NYU, and USC. He is also a facilitator of the executive education programs at Caltech. In this episode we discuss the following: The skills that got us to where we are may not be sufficient to get us to where we want to go, given the rapidly changing world. So, we need to continually upscale or rescale, to prepare ourselves to do something adjacent or something different. For Ravin, the journey of reinvention is his destination. Seek to continually reinvent yourself.   Connect on Social Media: X: https://twitter.com/nate_meikle LinkedIn: https://www.linkedin.com/in/natemeikle/ Instagram: https://www.instagram.com/nate_meikle/ Youtube: https://www.youtube.com/@nate.meikle

Today's daf is sponsored by Shulamith and Joel Cohn in loving memory of "Bubby," Rebbitzen Esther Predmesky whose yahrzeit is today, asara b'tevet. Today's day is sponsored by the Hadran Women of Long Island in honor of the birth of a grandson, son of Naomi and Dani Weinberger, to our friend and co-learner, Deena Rabinovich. "May the entire family enjoy much nachat from the new arrival as he grows l'Torah (and l'daf), l'chuppa and l'maasim tovim.  May we all continue to celebrate smachot "ad beli dai." Ravin brings (in the name of Rabbi Yochanan) a fourth explanation for Rabbi Meir's position that allows litigants to disqualify witnesses. Reish Lakish's choice of words showed respect for Rabbi Meir, which leads the Gemara into a broader discussion about scholarly respect for one another. Through various interpretations of verses (primarily from Zechariah), the Gemara contrasts the behavior of scholars in Israel and Babylonia. The Israeli rabbis are portrayed as having mutual respect, while the Babylonian rabbis are described as lacking such respect. The text then explores complex scenarios about litigant rights. If someone accepts a single witness, a relative of the opposing party as witness or judge, or agrees to a weaker oath than required, can they later change their mind? This raises questions about whether this debate applies only to cases where the litigant is forgiving a claim (making it more likely they intended to commit to the outcome), or even to cases where they must pay (less likely they intended to commit). There's also discussion about whether this applies before or after the court's ruling. Who is disqualified from being a witness?  Why is someone who gambled not allowed to testify - is it because of asmachta (problematic conditional commitments) or because not having legitimate employment raises concerns they might be bribed to give false testimony?

Join Ravin Jesuthasan as he delves into the shifting paradigms of work and education. In this enlightening episode, Ravin discusses the historical and future impacts of automation and AI on job structures and educational methodologies. Explore how these technologies are reshaping the skills landscape and what that means for future generations and the global economy. Subscribe for ad-free interviews and bonus episodes https://plus.acast.com/s/the-unmistakable-creative-podcast. Hosted on Acast. See acast.com/privacy for more information.

Is KJ ready to become a crossbow-only hunter? Ravin Crossbows were developed to extend hunting season and be more effective in the field. Nick Collier took the Ravin R29 and R18 for a spin and was blown away with their ease-of-use and accuracy. This Gun Talk Hunt is brought to you by EOTECH, Rossi USA, Ruger, Timney Triggers, Range Ready, Vortex Optics and Silencer Central.For more content, subscribe to Gun Talk at guntalktv.com, on Gun Talk's Roku, Apple TV, iOS app, Android app, or find Gun Talk on YouTube, Facebook, Instagram, X and guntalk.com. Listen to all Gun Talk Podcasts with Spreaker, iHeart, Apple Podcasts, Spotify or wherever you find podcasts.Copyright ©2024 Freefire Media, LLCGun Talk Hunt 09.23.24